Vincerx Pharma, Inc. (VINC)
OTCMKTS
· Delayed Price · Currency is USD
0.0450
+0.0010 (2.27%)
At close: Jul 1, 2025
Vincerx Pharma Market Cap
Vincerx Pharma has a market cap or net worth of $230.31 thousand as of July 1, 2025. Its market cap has decreased by -98.91% in one year.
Market Cap
230.31K
Enterprise Value
-4.21M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.05
Market Cap Chart
Since May 27, 2020, Vincerx Pharma's market cap has decreased from 22.32M to 230.31K, a decrease of -98.97%. That is a compound annual growth rate of -59.24%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 30, 2025 | 230.31K | -97.40% |
Dec 31, 2024 | 8.84M | -64.95% |
Dec 29, 2023 | 25.23M | 16.73% |
Dec 30, 2022 | 21.61M | -89.91% |
Dec 31, 2021 | 214.20M | -26.75% |
Dec 31, 2020 | 292.41M | 1,210.19% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Endo, Inc. | 1.60B |
Veradigm | 781.22M |
Elite Pharmaceuticals | 759.65M |
Nika Pharmaceuticals | 708.22M |
Tian'an Technology Group | 628.15M |
Glass House Brands | 442.61M |
American Oncology Network | 433.75M |
Northwest Biotherapeutics | 349.23M |